- Home
- FUSB vs ASRT Comparison
FUSB vs ASRT Comparison
Compare FUSB & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUSB | ASRT |
|---|---|---|
| Founded | 1952 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.6M | 75.1M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | FUSB | ASRT |
|---|---|---|
| Price | $14.14 | $11.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 6.2K | ★ 74.5K |
| Earning Date | 01-23-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | $36,068,000.00 | ★ $137,354,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.10 | ★ N/A |
| Revenue Growth | N/A | ★ 9.22 |
| 52 Week Low | $10.30 | $7.71 |
| 52 Week High | $14.79 | $15.15 |
Technical Indicators
Market Signals| Indicator | FUSB | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 54.46 | 87.55 |
| Support Level | $13.75 | $9.11 |
| Resistance Level | $14.23 | $10.39 |
| Average True Range (ATR) | 0.18 | 0.61 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 55.17 | 91.03 |
Price Performance
Historical ComparisonAbout FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.